GeneDx Holdings Corp. (WGS) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.69x

GeneDx Holdings Corp. (WGS) has a Cash Flow Reinvestment Rate of 0.69x as of September 2025, reinvesting $10.86 Million (capex $6.17 Million plus investments $-4.69 Million) from operating cash flow of $15.77 Million. Check WGS cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.69x
(Capex + Investments) / Operating CF

Total Reinvested

$10.86 Million
Capex + Investments

Operating Cash Flow

$15.77 Million
USD

Capital Expenditures

$6.17 Million
USD

GeneDx Holdings Corp. Cash Flow Reinvestment Rate (2025–2025)

Historical reinvestment intensity for GeneDx Holdings Corp. across 1 annual periods. Explore cash flow to debt ratio of GeneDx Holdings Corp. to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for GeneDx Holdings Corp. (2025–2025)

Year-by-year capital reinvestment analysis for GeneDx Holdings Corp.. For live market cap and broader valuation context, see WGS market cap.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 0.86x $28.66 Million $33.28 Million $19.02 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow